Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025
Verona Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -81.19 | -173.42 | -54.37 | -68.7 | -55.57 | -65.15 |
Depreciation & Amortization | 1.11 | 1.06 | 0.68 | 0.64 | 0.63 | 0.62 |
Other Amortization | 2.37 | 1.3 | 0.12 | 0.08 | 0.11 | 0.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.29 |
Stock-Based Compensation | 93.68 | 41.24 | 19.01 | 14.12 | 25.43 | 22.18 |
Other Operating Activities | 9.87 | 13.35 | -1.76 | 4.74 | -17.3 | -0.92 |
Change in Accounts Receivable | -82.86 | -31.5 | - | - | - | - |
Change in Inventory | -14.52 | -8.22 | - | - | - | - |
Change in Accounts Payable | -0.72 | 7.87 | 0.49 | -7.15 | 9.87 | -1.4 |
Change in Income Taxes | -1.87 | 14.68 | -2.14 | 4.1 | -6.78 | 0.77 |
Change in Other Net Operating Assets | 1.63 | 11.43 | -12.24 | -7.69 | 10.36 | -1.48 |
Operating Cash Flow | -72.49 | -122.2 | -50.22 | -59.86 | -33.25 | -45.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -1.07 | -0.58 | - | -0.03 | -0.01 | -0.08 |
Investment in Securities | - | - | - | - | - | 9.79 |
Investing Cash Flow | -1.07 | -0.58 | - | -0.03 | -0.01 | 9.71 |
Long-Term Debt Issued | - | 122.5 | 38.71 | 10 | - | 5 |
Long-Term Debt Repaid | - | -52.26 | - | -5.85 | - | - |
Net Debt Issued (Repaid) | 122.5 | 70.24 | 38.71 | 4.15 | - | 5 |
Issuance of Common Stock | 112.2 | 102.9 | 58.86 | 151.17 | 0.73 | 200.2 |
Repurchase of Common Stock | -124.61 | -15.45 | -4.69 | -4.72 | -6.85 | - |
Other Financing Activities | -4.61 | 93.09 | -0.01 | -9.78 | - | -12.86 |
Financing Cash Flow | 105.47 | 250.78 | 92.87 | 140.82 | -6.12 | 192.34 |
Foreign Exchange Rate Adjustments | 1.51 | -0.01 | 1.3 | -1.48 | -0.22 | 0.58 |
Net Cash Flow | 33.42 | 127.99 | 43.95 | 79.45 | -39.61 | 157.56 |
Free Cash Flow | -73.56 | -122.78 | -50.22 | -59.89 | -33.27 | -45.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -33.18% | -290.41% | - | -13076.64% | -83.17% | - |
Free Cash Flow Per Share | -0.88 | -1.51 | -0.63 | -0.91 | -0.56 | -1.37 |
Levered Free Cash Flow | -57.39 | -68.93 | -36.63 | -34.75 | 2.1 | -18.4 |
Unlevered Free Cash Flow | -36.5 | -55.52 | -35.46 | -34.5 | 2.19 | -18.39 |
Cash Interest Paid | 24.71 | 10.33 | 2.01 | 0.35 | 0.22 | 0.01 |
Cash Income Tax Paid | 9.82 | 0.64 | 1.25 | 0.12 | 0 | 0.01 |
Change in Working Capital | -98.34 | -5.74 | -13.9 | -10.74 | 13.44 | -2.11 |